| Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes B Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, S Hantel, ... New england journal of medicine 373 (22), 2117-2128, 2015 | 13499 | 2015 |
| Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetologia 55 (6), 1577-1596, 2012 | 6861 | 2012 |
| Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetes care 41 (12), 2669, 2018 | 6108* | 2018 |
| Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetes care 38 (1), 140-149, 2015 | 3793 | 2015 |
| 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study … JB Buse, DJ Wexler, A Tsapas, P Rossing, G Mingrone, C Mathieu, ... Diabetes care 43 (2), 487-493, 2020 | 1967 | 2020 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1549 | 2018 |
| Sodium–glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis D Vasilakou, T Karagiannis, E Athanasiadou, M Mainou, A Liakos, ... Annals of internal medicine 159 (4), 262-274, 2013 | 1194 | 2013 |
| Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetologia 58 (3), 429-442, 2015 | 934 | 2015 |
| American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach … SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetes care 35 (6), 1364-1379, 2012 | 859 | 2012 |
| Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis T Karagiannis, P Paschos, K Paletas, DR Matthews, A Tsapas Bmj 344, 2012 | 605 | 2012 |
| Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis E Bekiari, K Kitsios, H Thabit, M Tauschmann, E Athanasiadou, ... bmj 361, 2018 | 469 | 2018 |
| Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis A Tsapas, I Avgerinos, T Karagiannis, K Malandris, A Manolopoulos, ... Annals of internal medicine 173 (4), 278-286, 2020 | 329 | 2020 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related … VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ... Metabolism 71, 17-32, 2017 | 317 | 2017 |
| Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta‐analysis A Liakos, T Karagiannis, E Athanasiadou, M Sarigianni, M Mainou, ... Diabetes, Obesity and Metabolism 16 (10), 984-993, 2014 | 261 | 2014 |
| Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis T Karagiannis, I Avgerinos, A Liakos, S Del Prato, DR Matthews, A Tsapas, ... Diabetologia 65 (8), 1251-1261, 2022 | 245 | 2022 |
| Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms KI Bougioukas, A Liakos, A Tsapas, E Ntzani, AB Haidich Journal of clinical epidemiology 93, 9-24, 2018 | 237 | 2018 |
| Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis ML Griebeler, OL Morey-Vargas, JP Brito, A Tsapas, Z Wang, ... Annals of internal medicine 161 (9), 639-649, 2014 | 227 | 2014 |
| A systematic review and meta-analysis of tests to predict wound healing in diabetic foot Z Wang, R Hasan, B Firwana, T Elraiyah, A Tsapas, L Prokop, JL Mills Sr, ... Journal of vascular surgery 63 (2), 29S-36S. e2, 2016 | 188 | 2016 |
| Safety of dipeptidyl peptidase 4 inhibitors: a perspective review T Karagiannis, P Boura, A Tsapas Therapeutic advances in drug safety 5 (3), 138-146, 2014 | 166 | 2014 |
| A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome R Hasan, B Firwana, T Elraiyah, JP Domecq, G Prutsky, M Nabhan, ... Journal of vascular surgery 63 (2), 22S-28S. e2, 2016 | 154 | 2016 |
Eleni BekiariAssociate Professor, Aristotle University Thessalonikiبريد إلكتروني تم التحقق منه على auth.gr
